E Fund Management Co., Ltd. Acadia Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

$1.8 Billion
Q2 2024

A detailed history of E Fund Management Co., Ltd. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 18,528 shares of ACAD stock, worth $274,029. This represents 0.02% of its overall portfolio holdings.

Number of Shares

18,528

Previous 18,488 0.22%

Holding current value

$274,029

Previous $341,000 11.73%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $584 - $736	40 Added 0.22%	18,528 $301,000
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $78,364 - $135,938	-4,405 Reduced 19.24%	18,488 $341,000
Q4 2023 Feb 06, 2024	BUY	$20.78 - $31.77 $116,471 - $178,070	5,605 Added 32.42%	22,893 $716,000
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $16,255 - $26,106	-780 Reduced 4.32%	17,288 $360,000
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $14,222 - $20,494	-799 Reduced 4.23%	18,068 $433,000
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $168,144 - $215,538	-10,303 Reduced 35.32%	18,867 $355,000
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $25,034 - $32,844	1,763 Added 6.43%	29,170 $464,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $25,200 - $32,630	1,786 Added 6.97%	27,407 $448,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $182,764 - $382,386	14,048 Added 121.39%	25,621 $361,000
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $242,338 - $318,257	11,573 New	11,573 $280,000
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $179,199 - $289,131	-10,673 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $87,500 - $137,349	5,545 Added 108.13%	10,673 $177,000
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $128,302 - $281,988	5,128 New	5,128 $0

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Acadia Pharmaceuticals Inc Transaction History